What is CAR-T?

CAR-T therapy is a type of immunotherapy that uses a person’s own immune cells, called T cells, and makes them stronger so they can identify and attack cancer cells. First, T cells are removed from a patient’s blood. Next, the cells are modified in a laboratory, adding the gene for a molecule receptor called a chimeric antigen receptor (CAR). Millions of these CAR-T cells are grown in the laboratory, and then given back to the patient through an infusion. These new cells can seek out cancer cells, attach to them and destroy them.

Why Choose Hopkins for CAR-T?

Our center is a National Cancer Institute-designated Comprehensive Cancer Center with a long history of accomplishments in the field of blood and bone marrow cancers. Our experts led by CAR-T expert Dr. Tania Jain, helped develop, and continually expand, the field of bone marrow transplantation and cellular therapy.

Our History

Frequently Asked Questions